Safety and efficacy of foscarnet for the management of ganciclovir-resistant or refractory cytomegalovirus infections: A single-center study.
Brett PierceChad L RichardsonLisa LaclocheAnne AllenMichael G IsonPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2018)
Although mortality was high in this population, foscarnet use, with proper precautions, was generally safe and significant renal dysfunction was lower than previously reported in other sources, even with extended use.